Organogenesis Holdings Inc. Balance Sheet
ORGO|10 years of annual SEC 10-K data (FY2016-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
Organogenesis Holdings Inc. had $599M in total assets and $263M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93.7M | $135.6M | $103.8M | $102.5M | $113.9M | - | - | - | - | - |
| Accounts Receivable | $217.5M | $109.9M | $82.0M | $89.5M | $82.5M | $56.8M | $39.4M | $34.1M | - | - |
| Inventory | $29.6M | $26.2M | $28.3M | $24.8M | $25.0M | $27.8M | $22.9M | $13.3M | - | - |
| Current Assets | $362.2M | $285.9M | $225.0M | $222.6M | $227.0M | $174.3M | $125.6M | $71.1M | $294.4K | $1.4M |
| PP&E (Net) | $103.7M | $89.1M | $116.2M | $102.5M | $79.2M | $60.1M | $47.2M | $39.6M | - | - |
| Goodwill | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $25.5M | $25.5M | - | - |
| Total Assets | $598.7M | $497.9M | $460.0M | $449.4M | $443.3M | $294.5M | $220.7M | $163.7M | $312.8M | $311.4M |
| Current Liabilities | $100.1M | $77.5M | $80.5M | $75.0M | $82.0M | $68.2M | $59.9M | $66.4M | $3.9M | $478.4K |
| Shareholders' Equity | $262.9M | $265.7M | $241.3M | $141.8M | $52.0M | $47.0M | -$15.3M | -$16.0M | -$162 | $0 |